EVISA member Eurofins achieves growth in sales of almost 50%
Brussels/ Nantes, August 3, 2006
Over the period from January 1 until June 30, 2006, Eurofins achieved sales of € 150.9 million, which corresponds to a growth of 49% compared with HY1/ 2005 (€ 101.0 million). Therewith, Eurofins is well in line with its objective to reach a turnover of € 300 million for the full year 2006.
In the second quarter of 2006, Eurofins reached sales of € 80.7
million representing a growth of 44% compared with Q2/ 2005 (€ 56.1
Besides the organic growth, a major part of the sales increase is
due to various acquisitions and outsourcing agreements carried out
during the past 12 months, such as GAB Biotechnologie (Germany), LEM,
Pharmacontrol, Optimed (all France), Focus Bio-Inova (France/USA),
AvTech (USA), Steins (Denmark), Direct Laboratories and Agriseach (both
The full results of the first half-year of 2006 will be published on August 29, 2006.
Source: Eurofins Related News EVISA News, June 16, 2005: EVISA member eurofins strengthens its position EVISA News, July 19, 2006: EVISA's member eurofins now clear No. 1 in the Scandinavian food testing market